The AHA July 20 submitted comments on proposed Centers for Medicare & Medicaid Services regulations that would support state flexibility in Medicaid drug value-based purchasing arrangements and other changes to the Medicaid drug rebate program for fiscal year 2021.

“The AHA supports innovations in drug purchasing arrangements, so long as these arrangements preserve or enhance patient access to critical medications and result in lower drug costs,” AHA wrote. “As CMS continues to pursue an increase in VBP opportunity, we urge the agency to consider the appropriate balance that must be struck to make these arrangements work effectively for the Medicaid program as well as throughout the health care delivery system.”

AHA also urged the agency to extend the comment period beyond the current 30-day period to allow stakeholders’ thoughtful and careful consideration for assessing the implications of applying VBP arrangements for Medicaid drug coverage and purchasing.

Related News Articles

Headline
The Government Accountability Office yesterday named five new members to the Medicaid and CHIP Payment and Access Commission, which advises Congress on…
Headline
The AHA and Texas Hospital Association today filed a friend-of-the-court brief supporting the Texas Health and Human Services Commission and several Texas…
Headline
A recent Health Affairs Blog post by physicians “gives an incomplete account of the implications of allowing new and expanded physician-owned hospitals to bill…
Blog
A recent Health Affairs post gives an incomplete account of the implications of allowing new and expanded physician-owned hospitals to bill Medicare and…
Headline
The Medicaid and Children’s Health Insurance Program Payment and Access Commission this week released its March report to Congress, which recommends…
Headline
The Centers for Medicare & Medicaid Services today released a request for applications for practices and payers to participate in the Primary Care First…